← Back to Clinical Trials
Recruiting NCT06998550

NCT06998550 Patient Experiences and the Role of Team Structures in Pulmonary Rehabilitation in Türkiye

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06998550
Status Recruiting
Phase
Sponsor Saglik Bilimleri Universitesi
Condition Pulmonary Disease
Study Type OBSERVATIONAL
Enrollment 384 participants
Start Date 2025-07-29
Primary Completion 2026-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age 80 Years
Study Type OBSERVATIONAL
Interventions
Patient Satisfaction QuestionnaireInstitutional Survey on PR Program Structure and Team Composition

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 384 participants in total. It began in 2025-07-29 with a primary completion date of 2026-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The PRETTY Study aims to evaluate patient satisfaction with pulmonary rehabilitation (PR) services across Türkiye and to investigate how satisfaction levels are related to the organizational structures and team compositions of the PR programs. This national, multicenter, cross-sectional observational study will also identify structural and organizational factors that may enhance patient-centered care and promote the standardization of PR services.

Eligibility Criteria

Patient Inclusion Criteria: * Age ≥18 years * Diagnosed with a respiratory condition (e.g., COPD, interstitial lung disease, asthma, bronchiectasis, etc.) * Completed a structured PR program (minimum duration and frequency as defined by national guidelines or center-specific protocols) * Willing and able to complete the online Patient Satisfaction Questionnaire * Able to provide informed consent Patient Exclusion Criteria: * Ongoing participation in a PR program (only completed cases will be included) * Inability to complete the questionnaire due to cognitive or language barriers without a caregiver Coordinator Inclusion Criteria: * Officially designated as the PR program coordinator or responsible team member * Affiliated with a healthcare institution (public, university-affiliated, or private) in Türkiye that provides PR services * Willing to complete the Institutional Survey Form regarding team structure, service delivery, and organizational characteristics * Authorized by the institution to provide structural data related to the PR unit Coordinator Exclusion Criteria: * PR services provided on an informal or ad-hoc basis without a designated team or structure * Institutions not offering a structured PR program

Contact & Investigator

Central Contact

Esra Pehlivan, Assoc Professor

✉ esra.pehlivan@sbu.edu.tr

Frequently Asked Questions

Who can join the NCT06998550 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Pulmonary Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06998550 currently recruiting?

Yes, NCT06998550 is actively recruiting participants. Contact the research team at esra.pehlivan@sbu.edu.tr for enrollment information.

Where is the NCT06998550 trial being conducted?

This trial is being conducted at Istanbul, Turkey (Türkiye).

Who is sponsoring the NCT06998550 clinical trial?

NCT06998550 is sponsored by Saglik Bilimleri Universitesi. The trial plans to enroll 384 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology